28
Participants
Start Date
July 11, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Superior laryngeal nerve block - Intervention (Bupivacaine and triamcinolone acetonide suspension)
Patients will receive a superior laryngeal nerve block consisting of 1 ml of 0.25% bupivacaine and 1mL of triamcinolone acetate 40 mg/ml to the neck on the side of the vocal cord lesion during their surgery.
Superior laryngeal nerve block - Placebo (saline)
Patients will receive a saline placebo of 2mL saline to the neck on the side of the vocal cord lesion during their surgery.
Rutgers New Jersey Medical School, Newark
Rutgers, The State University of New Jersey
OTHER